Amid COVID-19 Vaccine Confusion, New Tool Helps Guide Decision-Making

Washington, DC, Jan. 14, 2026 (GLOBE NEWSWIRE) — The Asthma and Allergy Foundation of America (AAFA) announces the release of a new COVID-19 Vaccine Decision Aid, designed to help people decide if they should get the vaccine this year. The decision aid is endorsed by the American College of Allergy, Asthma, and Immunology (ACAAI), the […]

Amid COVID-19 Vaccine Confusion, New Tool Helps Guide Decision-Making

Amid COVID-19 Vaccine Confusion, New Tool Helps Guide Decision-Making AAFA releases decision aid to provide information, guide conversations with doctors GlobeNewswire January 14, 2026 Washington, DC, Jan. 14, 2026 (GLOBE NEWSWIRE) — The Asthma and Allergy Foundation of America (AAFA) announces the release of a new COVID-19 Vaccine Decision Aid, designed to help people decide

She Lost 115 Pounds by Playing the Long Game

Nutrishop franchisee’s four-year transformation challenges the January reset mindset In a season dominated by bold promises and overnight transformations, one woman’s story stands out for a different reason: it took time. Over four years, Dana Smith has lost a total of 115 pounds, not through extremes or shortcuts, but through consistency, patience and a willingness

Freddy’s Finishes 2025 with Record Franchise Growth and an Expanding Pipeline for Development

— The fast-casual restaurant brand signed 22 multi-unit development agreements last year to develop 118 restaurants — 51 new Freddy’s restaurants opened in 2025, 7 slated for Q1 of 2026 — Solidifying its growth trajectory, Freddy’s climbed to No. 79 on the 2025 Franchise Times Top 400 List Freddy’s – the fast-casual restaurant concept known

Canada's Luxury Housing Market Becomes Increasingly Regional as Prices Hold

Toronto and Vancouver: softer sales volumes as buyers took a more measured approach amid higher price thresholds and greater inventory choice. Ottawa, Montréal and Halifax: increased transaction activity, driven by value-oriented luxury segments, stable local demand and improved borrowing conditions. Nationally: average prices remained largely unchanged, underscoring the market’s underlying resilience. New York, New York

JHX Investors Have Opportunity to Join James Hardie Industries plc Fraud Investigation with the Schall Law Firm

(NYSE:JHX), LOS ANGELES, Jan. 14, 2026 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of former investors of The AZEK Company (“AZEK”) who received shares in James Hardie Industries plc (“James Hardie” or “the Company”) (NYSE: JHX) in connection with James Hardie's

JHX Investors Have Opportunity to Join James Hardie Industries plc Fraud Investigation with the Schall Law Firm

JHX Investors Have Opportunity to Join James Hardie Industries plc Fraud Investigation with the Schall Law Firm GlobeNewswire January 14, 2026 LOS ANGELES, Jan. 14, 2026 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of former investors of The AZEK Company (“AZEK”)

Ensora Health Becomes New Corporate Partner of ASHA

Rockville, MD, Jan. 14, 2026 (GLOBE NEWSWIRE) — The American Speech-Language-Hearing Association (ASHA) announced today that Ensora Health–the provider of Fusion, a leading electronic health record and practice management platform tailored for speech-language pathologists (SLPs)–has become an ASHA Corporate Partner. ASHA's partnership with Ensora Health will provide member SLPs more administrative support in service of

Ensora Health Becomes New Corporate Partner of ASHA

Ensora Health Becomes New Corporate Partner of ASHA Partnership Will Enhance Member SLP Care Through Streamlined Workflow GlobeNewswire January 14, 2026 Rockville, MD, Jan. 14, 2026 (GLOBE NEWSWIRE) — The American Speech-Language-Hearing Association (ASHA) announced today that Ensora Health–the provider of Fusion, a leading electronic health record and practice management platform tailored for speech-language pathologists

Class Action Litigation Filed by Pomerantz LLP Against Skye Bioscience, Inc. – SKYE

NEW YORK CITY, NY / ACCESS Newswire / January 14, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Skye Bioscience, Inc. ("Skye" or the "Company") (NASDAQ:SKYE) and certain officers.�� The class action, filed in the United States District Court for the Southern District of California, and docketed under 25-cv-03177,

Scroll to Top